Cargando…
Sialic Acid Binding Domains of CD22 Are Required For Negative Regulation of B Cell Receptor Signaling
CD22, a negative regulator of B cell antigen receptor signaling, binds glycoconjugates terminating in α2, 6 sialic acid. The physiological ligand(s) for CD22 remain unknown. We asked whether the sialic acid binding domains are necessary for CD22 to function as a negative regulator. We generated two...
Autores principales: | Jin, Lei, McLean, Paul A., Neel, Benjamin G., Wortis, Henry H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193702/ https://www.ncbi.nlm.nih.gov/pubmed/11994425 http://dx.doi.org/10.1084/jem.20011796 |
Ejemplares similares
-
The Ligand-binding Domain of CD22 Is Needed for Inhibition of the B Cell Receptor Signal, as Demonstrated by a Novel Human CD22-specific Inhibitor Compound
por: Kelm, Soerge, et al.
Publicado: (2002) -
Inhibition of the B Cell by CD22: A Requirement for Lyn
por: Smith, Kenneth G.C., et al.
Publicado: (1998) -
A requirement for Lim domain binding protein 1 in erythropoiesis
por: Li, LiQi, et al.
Publicado: (2010) -
Identification of CD22 Ligands on Bone Marrow Sinusoidal Endothelium Implicated in CD22-dependent Homing of Recirculating B Cells
por: Nitschke, Lars, et al.
Publicado: (1999) -
Surface Sialic Acids Taken from the Host Allow Trypanosome Survival in Tsetse Fly Vectors
por: Nagamune, Kisaburo, et al.
Publicado: (2004)